Umeå universitets logga

umu.sePublikationer
Ändra sökning
Länk till posten
Permanent länk

Direktlänk
Lindgren, Cecilia
Publikationer (10 of 21) Visa alla publikationer
Abrahamsson, A., Berner, A., Golebiewska-Pikula, J., Chaudhari, N., Keskitalo, E., Lindgren, C., . . . Chorell, E. (2025). Linker design principles for the precision targeting of oncogenic G-quadruplex DNA with G4-ligand-conjugated oligonucleotides. Bioconjugate chemistry, 36(4), 724-736
Öppna denna publikation i ny flik eller fönster >>Linker design principles for the precision targeting of oncogenic G-quadruplex DNA with G4-ligand-conjugated oligonucleotides
Visa övriga...
2025 (Engelska)Ingår i: Bioconjugate chemistry, ISSN 1043-1802, E-ISSN 1520-4812, Vol. 36, nr 4, s. 724-736Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

G-quadruplex (G4) DNA structures are noncanonical secondary structures found in key regulatory regions of the genome, including oncogenic promoters and telomeres. Small molecules, known as G4 ligands, capable of stabilizing G4s hold promise as chemical probes and therapeutic agents. Nevertheless, achieving precise specificity for individual G4 structures within the human genome remains a significant challenge. To address this, we expand upon G4-ligand-conjugated oligonucleotides (GL-Os), a modular platform combining the stabilizing properties of G4-ligands with the sequence specificity of guide DNA oligonucleotides. Central to this strategy is the linker that bridges the G4 ligand and the guide oligonucleotide. In this study, we develop multiple conjugation strategies for the GL-Os that enabled a systematic investigation of the linker in both chemical composition and length, enabling a thorough assessment of their impact on targeting oncogenic G4 DNA. Biophysical, biochemical, and computational evaluations revealed GL-Os with optimized linkers that exhibited enhanced binding to target G4s, even under thermal or structural stress. Notably, longer linkers broadened the range of targetable sequences without introducing steric hindrance, thereby enhancing the platform’s applicability across diverse genomic contexts. These findings establish GL-Os as a robust and versatile tool for the selective targeting of individual G4s. By facilitating precise investigations of G4 biology, this work provides a foundation for advancing G4-targeted therapeutic strategies and exploring their role in disease contexts.

Ort, förlag, år, upplaga, sidor
American Chemical Society (ACS), 2025
Nationell ämneskategori
Biokemi
Identifikatorer
urn:nbn:se:umu:diva-237287 (URN)10.1021/acs.bioconjchem.5c00008 (DOI)001448909600001 ()40112195 (PubMedID)2-s2.0-105000394779 (Scopus ID)
Forskningsfinansiär
Vetenskapsrådet, VR-MH 2023-02160Vetenskapsrådet, VR-NT 2021-04805Kempestiftelserna, JCK-3159Kempestiftelserna, SMK21-0059Knut och Alice Wallenbergs StiftelseCancerfonden, 23 2793 PjVetenskapsrådet, VR-MH 2023-02160Vetenskapsrådet, VR-NT 2021-04805Kempestiftelserna, JCK-3159Kempestiftelserna, SMK21-0059Knut och Alice Wallenbergs StiftelseCancerfonden, 23 2793 Pj
Tillgänglig från: 2025-04-07 Skapad: 2025-04-07 Senast uppdaterad: 2025-05-28Bibliografiskt granskad
Hainzl, T., Scortti, M., Lindgren, C., Grundström, C., Krypotou, E., Vázquez-Boland, J. A. & Sauer-Eriksson, A. E. (2025). Structural basis of promiscuous inhibition of Listeria virulence activator PrfA by oligopeptides. Cell Reports, 44(2), Article ID 115290.
Öppna denna publikation i ny flik eller fönster >>Structural basis of promiscuous inhibition of Listeria virulence activator PrfA by oligopeptides
Visa övriga...
2025 (Engelska)Ingår i: Cell Reports, ISSN 2639-1856, E-ISSN 2211-1247, Vol. 44, nr 2, artikel-id 115290Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

The facultative pathogen Listeria monocytogenes uses a master regulator, PrfA, to tightly control the fitness-costly expression of its virulence factors. We found that PrfA activity is repressed via competitive occupancy of the binding site for the PrfA-activating cofactor, glutathione, by exogenous nutritional oligopeptides. The inhibitory peptides show different sequence and physicochemical properties, but how such a wide variety of oligopeptides can bind PrfA was unclear. Using crystal structure analysis of PrfA complexed with inhibitory tri- and tetrapeptides, we show here that the binding promiscuity is due to the ability of PrfA β5 in the glutathione-binding inter-domain tunnel to establish parallel or antiparallel β sheet-like interactions with the peptide backbone. Spacious tunnel pockets provide additional flexibility for unspecific peptide accommodation while providing selectivity for hydrophobic residues. Hydrophobic contributions from two adjacent peptide residues appear to be critical for efficient PrfA inhibitory binding. In contrast to glutathione, peptide binding prevents the conformational change required for the correct positioning of the DNA-binding helix-turn-helix motifs of PrfA, effectively inhibiting virulence gene expression.

Ort, förlag, år, upplaga, sidor
Elsevier, 2025
Nyckelord
CP: Microbiology, crystal structures of PrfA in complex with oligopeptides, Listeria pathogenesis, Listeria virulence regulation, non-specific oligopeptide-protein binding, oligopeptide-mediated PrfA regulation, peptide-glutathione competitive binding to PrfA, peptide-mediated transcription factor regulation, PrfA allosteric control, PrfA-peptide 3D structure analysis, promiscuous PrfA inhibition by oligopeptides
Nationell ämneskategori
Biokemi Molekylärbiologi
Identifikatorer
urn:nbn:se:umu:diva-235844 (URN)10.1016/j.celrep.2025.115290 (DOI)001428945700001 ()2-s2.0-85217797793 (Scopus ID)
Forskningsfinansiär
Vetenskapsrådet, 2015-03607Vetenskapsrådet, 2019-03771Vetenskapsrådet, 2018-07152KempestiftelsernaFamiljen Erling-Perssons StiftelseVinnova, 2018-04969Forskningsrådet Formas, 2019-02496
Tillgänglig från: 2025-02-25 Skapad: 2025-02-25 Senast uppdaterad: 2025-04-24Bibliografiskt granskad
Romero-Castillo, L., Pandey, R. K., Xu, B., Beusch, C. M., Oliveira-Coelho, A., Zeqiraj, K., . . . Holmdahl, R. (2025). Tolerogenic antigen-specific vaccine induces VISTA-enriched regulatory T cells and protects against arthritis in DRB1∗04:01 mice. Molecular Therapy
Öppna denna publikation i ny flik eller fönster >>Tolerogenic antigen-specific vaccine induces VISTA-enriched regulatory T cells and protects against arthritis in DRB1∗04:01 mice
Visa övriga...
2025 (Engelska)Ingår i: Molecular Therapy, ISSN 1525-0016, E-ISSN 1525-0024Artikel i tidskrift (Refereegranskat) Epub ahead of print
Abstract [en]

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint inflammation, cartilage damage, and bone erosion. Despite improvements with the introduction of biological disease-modifying anti-rheumatic drugs (DMARDs), RA remains an incurable life-long disease. Advancements in peptide-based vaccination may open new avenues for treating autoimmune diseases, including RA, by inducing immune tolerance while maintaining normal immune function. We have already demonstrated the efficacy of a potent vaccine against RA, consisting of the mouse major histocompatibility complex class II (Aq) protein bound to the immunodominant type II collagen peptide COL2259-273, which needed to be galactosylated at position 264. To translate the vaccine to humans and to further enhance vaccine efficacy, we modified the glycine residue at position 265 and conjugated it with the human DRB1∗04:01 molecule. Remarkably, this modified vaccine (named DR4-AL179) provided robust effectiveness in suppressing arthritis in DRB1∗04:01-expressing mice without the need for galactosylation at position 264. DR4-AL179 vaccination induces tolerance involving multiple immunoregulatory pathways, including the activation of V-type immunoglobulin domain-containing suppressor of T cell activation (VISTA)-positive nonconventional regulatory T cells, which contribute to a potent suppressive response preventing arthritis development in mice. This modified RA vaccine offers a novel therapeutic potential for human autoimmune diseases.

Ort, förlag, år, upplaga, sidor
Elsevier, 2025
Nyckelord
COL2, immune checkpoints, MHCII, regulatory T cells, rheumatoid arthritis, T cell tolerance, tolerogenic, vaccine, VISTA
Nationell ämneskategori
Immunologi inom det medicinska området Reumatologi Autoimmunitet och inflammation
Identifikatorer
urn:nbn:se:umu:diva-238834 (URN)10.1016/j.ymthe.2025.04.034 (DOI)40285352 (PubMedID)2-s2.0-105004434061 (Scopus ID)
Forskningsfinansiär
Vetenskapsrådet, 2024-02575Novo Nordisk fondenKnut och Alice Wallenbergs Stiftelse, 2019.0059Stiftelsen Lars Hiertas MinneReumatikerförbundetKonung Gustaf V:s Jubileumsfond, SGI-2023-0993
Tillgänglig från: 2025-06-04 Skapad: 2025-06-04 Senast uppdaterad: 2025-07-11
Kumari, R., Lindgren, C., Kumar, R., Forsgren, N., Andersson, C. D., Ekström, F. & Linusson, A. (2024). Enzyme dynamics determine the potency and selectivity of inhibitors targeting disease-transmitting mosquitoes. ACS - Infectious Diseases, 10(10), 3664-3680
Öppna denna publikation i ny flik eller fönster >>Enzyme dynamics determine the potency and selectivity of inhibitors targeting disease-transmitting mosquitoes
Visa övriga...
2024 (Engelska)Ingår i: ACS - Infectious Diseases, E-ISSN 2373-8227, Vol. 10, nr 10, s. 3664-3680Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Vector control of mosquitoes with insecticides is an important tool for preventing the spread of mosquito-borne diseases including malaria, dengue, chikungunya, and Zika. Development of active ingredients for insecticides are urgently needed because existing agents exhibit off-target toxicity and are subject to increasing resistance. We therefore seek to develop noncovalent inhibitors of the validated insecticidal target acetylcholinesterase 1 (AChE1) from mosquitoes. Here we use molecular dynamics simulations to identify structural properties essential for the potency of reversible inhibitors targeting AChE1 from Anopheles gambiae (AgAChE1), the malaria-transmitting mosquito, and for selectivity relative to the vertebrate Mus musculus AChE (mAChE). We show that the collective motions of apo AgAChE1 and mAChE differ, with AgAChE1 exhibiting less dynamic movement. Opening and closing of the gorge, which regulates access to the catalytic triad, is enabled by different mechanisms in the two species, which could be linked to their differing amino acid sequences. Inhibitor binding reduced the overall magnitude of dynamics of AChE. In particular, more potent inhibitors reduced the flexibility of the Ω loop at the entrance of the gorge. The selectivity of inhibitors for AgAChE1 over mAChE derives from the positioning of the α-helix lining the binding gorge. Our findings emphasize the need to consider dynamics when developing inhibitors targeting this enzyme and highlight factors needed to create potent and selective AgAChE1 inhibitors that could serve as active ingredients to combat disease-transmitting mosquitoes.

Ort, förlag, år, upplaga, sidor
American Chemical Society (ACS), 2024
Nyckelord
acetylcholinesterase, inhibitors, molecular dynamics, mosquitoes, vector control
Nationell ämneskategori
Organisk kemi Biokemi Molekylärbiologi
Identifikatorer
urn:nbn:se:umu:diva-230609 (URN)10.1021/acsinfecdis.4c00531 (DOI)001315756000001 ()39291389 (PubMedID)2-s2.0-85205394034 (Scopus ID)
Forskningsfinansiär
Vetenskapsrådet, 2018-05176Vetenskapsrådet, 2022-04331
Tillgänglig från: 2024-10-08 Skapad: 2024-10-08 Senast uppdaterad: 2025-02-20Bibliografiskt granskad
Tükenmez, H., Singh, P., Sarkar, S., Çakır, M., Oliveira, A. H., Lindgren, C., . . . Johansson, J. (2023). A highly substituted ring-fused 2-pyridone compound targeting PrfA and the efflux regulator BrtA in listeria monocytogenes [Letter to the editor]. mBio, 14(3), Article ID e0044923.
Öppna denna publikation i ny flik eller fönster >>A highly substituted ring-fused 2-pyridone compound targeting PrfA and the efflux regulator BrtA in listeria monocytogenes
Visa övriga...
2023 (Engelska)Ingår i: mBio, ISSN 2161-2129, E-ISSN 2150-7511, Vol. 14, nr 3, artikel-id e0044923Artikel i tidskrift, Letter (Refereegranskat) Published
Abstract [en]

Listeria monocytogenes is a facultative Gram-positive bacterium that causes listeriosis, a severe foodborne disease. We previously discovered that ring-fused 2-pyridone compounds can decrease virulence factor expression in Listeria by binding and inactivating the PrfA virulence activator. In this study, we tested PS900, a highly substituted 2-pyridone that was recently discovered to be bactericidal to other Gram-positive pathogenic bacteria, such as Staphylococcus aureus and Enterococcus faecalis. We show that PS900 can interact with PrfA and reduce the expression of virulence factors. Unlike previous ring-fused 2-pyridones shown to inactivate PrfA, PS900 had an additional antibacterial activity and was found to potentiate sensitivity toward cholic acid. Two PS900-tolerant mutants able to grow in the presence of PS900 carried mutations in the brtA gene, encoding the BrtA repressor. In wild-type (WT) bacteria, cholic acid binds and inactivates BrtA, thereby alleviating the expression of the multidrug transporter MdrT. Interestingly, we found that PS900 also binds to BrtA and that this interaction causes BrtA to dissociate from its binding site in front of the mdrT gene. In addition, we observed that PS900 potentiated the effect of different osmolytes. We suggest that the increased potency of cholic acid and osmolytes to kill bacteria in the presence of PS900 is due to the ability of the latter to inhibit general efflux, through a yet-unknown mechanism. Our data indicate that thiazolino 2-pyridones constitute an attractive scaffold when designing new types of antibacterial agents.

IMPORTANCE: Bacteria resistant to one or several antibiotics are a very large problem, threatening not only treatment of infections but also surgery and cancer treatments. Thus, new types of antibacterial drugs are desperately needed. In this work, we show that a new generation of substituted ring-fused 2-pyridones not only inhibit Listeria monocytogenes virulence gene expression, presumably by inactivating the PrfA virulence regulator, but also potentiate the bactericidal effects of cholic acid and different osmolytes. We identified a multidrug repressor as a second target of 2-pyridones. The repressor–2-pyridone interaction displaces the repressor from DNA, thus increasing the expression of a multidrug transporter. In addition, our data suggest that the new class of ring-fused 2-pyridones are efficient efflux inhibitors, possibly explaining why the simultaneous addition of 2-pyridones together with cholic acid or osmolytes is detrimental for the bacterium. This work proves conclusively that 2-pyridones constitute a promising scaffold to build on for future antibacterial drug design.

Ort, förlag, år, upplaga, sidor
American Society for Microbiology, 2023
Nyckelord
2-pyridones, BrtA, Listeria monocytogenes, PrfA, antibacterial, antibiotic
Nationell ämneskategori
Biokemi Molekylärbiologi Mikrobiologi inom det medicinska området Organisk kemi
Forskningsämne
molekylär cellbiologi
Identifikatorer
urn:nbn:se:umu:diva-214132 (URN)10.1128/mbio.00449-23 (DOI)000975886700001 ()37120759 (PubMedID)2-s2.0-85172894238 (Scopus ID)
Forskningsfinansiär
Familjen Erling-Perssons StiftelseNIH (National Institutes of Health), RO1AI134847-01A1NIH (National Institutes of Health), 1IU19AI157797-01Olle Engkvists stiftelseVinnova, 2019-05491Vetenskapsrådet, 2020-02005Vetenskapsrådet, 2018-04589Vetenskapsrådet, 202105040J
Tillgänglig från: 2023-09-05 Skapad: 2023-09-05 Senast uppdaterad: 2025-02-20Bibliografiskt granskad
Vidal-Albalat, A., Kindahl, T., Rajeshwari, R., Lindgren, C., Forsgren, N., Kitur, S., . . . Linusson, A. (2023). Structure-activity relationships reveal beneficial selectivity profiles of inhibitors targeting acetylcholinesterase of disease-transmitting mosquitoes. Journal of Medicinal Chemistry, 66(9), 6333-6353
Öppna denna publikation i ny flik eller fönster >>Structure-activity relationships reveal beneficial selectivity profiles of inhibitors targeting acetylcholinesterase of disease-transmitting mosquitoes
Visa övriga...
2023 (Engelska)Ingår i: Journal of Medicinal Chemistry, ISSN 0022-2623, E-ISSN 1520-4804, Vol. 66, nr 9, s. 6333-6353Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Insecticide resistance jeopardizes the prevention of infectious diseases such as malaria and dengue fever by vector control of disease-transmitting mosquitoes. Effective new insecticidal compounds with minimal adverse effects on humans and the environment are therefore urgently needed. Here, we explore noncovalent inhibitors of the well-validated insecticidal target acetylcholinesterase (AChE) based on a 4-thiazolidinone scaffold. The 4-thiazolidinones inhibit AChE1 from the mosquitoes Anopheles gambiae and Aedes aegypti at low micromolar concentrations. Their selectivity depends primarily on the substitution pattern of the phenyl ring; halogen substituents have complex effects. The compounds also feature a pendant aliphatic amine that was important for activity; little variation of this group is tolerated. Molecular docking studies suggested that the tight selectivity profiles of these compounds are due to competition between two binding sites. Three 4-thiazolidinones tested for in vivo insecticidal activity had similar effects on disease-transmitting mosquitoes despite a 10-fold difference in their in vitro activity.

Ort, förlag, år, upplaga, sidor
American Chemical Society (ACS), 2023
Nationell ämneskategori
Organisk kemi Läkemedelskemi
Identifikatorer
urn:nbn:se:umu:diva-208264 (URN)10.1021/acs.jmedchem.3c00234 (DOI)000979350900001 ()37094110 (PubMedID)2-s2.0-85156231351 (Scopus ID)
Forskningsfinansiär
Vetenskapsrådet, 2017-00664Kempestiftelserna
Tillgänglig från: 2023-05-24 Skapad: 2023-05-24 Senast uppdaterad: 2024-11-27Bibliografiskt granskad
Stael, S., Sabljić, I., Audenaert, D., Andersson, T., Tsiatsiani, L., Kumpf, R. P., . . . Van Breusegem, F. (2023). Structure-function study of a Ca2+-independent metacaspase involved in lateral root emergence. Proceedings of the National Academy of Sciences of the United States of America, 120(22), Article ID e2303480120.
Öppna denna publikation i ny flik eller fönster >>Structure-function study of a Ca2+-independent metacaspase involved in lateral root emergence
Visa övriga...
2023 (Engelska)Ingår i: Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, E-ISSN 1091-6490, Vol. 120, nr 22, artikel-id e2303480120Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Metacaspases are part of an evolutionarily broad family of multifunctional cysteine proteases, involved in disease and normal development. As the structure-function relationship of metacaspases remains poorly understood, we solved the X-ray crystal structure of an Arabidopsis thaliana type II metacaspase (AtMCA-IIf) belonging to a particular subgroup not requiring calcium ions for activation. To study metacaspase activity in plants, we developed an in vitro chemical screen to identify small molecule metacaspase inhibitors and found several hits with a minimal thioxodihydropyrimidine-dione structure, of which some are specific AtMCA-IIf inhibitors. We provide mechanistic insight into the basis of inhibition by the TDP-containing compounds through molecular docking onto the AtMCA-IIf crystal structure. Finally, a TDP-containing compound (TDP6) effectively hampered lateral root emergence in vivo, probably through inhibition of metacaspases specifically expressed in the endodermal cells overlying developing lateral root primordia. In the future, the small compound inhibitors and crystal structure of AtMCA-IIf can be used to study metacaspases in other species, such as important human pathogens, including those causing neglected diseases.

Ort, förlag, år, upplaga, sidor
Proceedings of the National Academy of Sciences (PNAS), 2023
Nyckelord
AtMCA-IIf crystal structure, cysteine protease, lateral root development, metacaspase, small chemical inhibitor
Nationell ämneskategori
Växtbioteknologi
Identifikatorer
urn:nbn:se:umu:diva-210280 (URN)10.1073/pnas.2303480120 (DOI)001041275500007 ()37216519 (PubMedID)2-s2.0-85159833521 (Scopus ID)
Forskningsfinansiär
Knut och Alice Wallenbergs Stiftelse, 2018.0026Knut och Alice Wallenbergs Stiftelse, 2021.0071
Tillgänglig från: 2023-06-21 Skapad: 2023-06-21 Senast uppdaterad: 2025-04-24Bibliografiskt granskad
Lindgren, C., Forsgren, N., Hoster, N., Akfur, C., Artursson, E., Edvinsson, L., . . . Linusson, A. (2022). Broad-Spectrum Antidote Discovery by Untangling the Reactivation Mechanism of Nerve-Agent-Inhibited Acetylcholinesterase. Chemistry - A European Journal, 28(40), Article ID e202200678.
Öppna denna publikation i ny flik eller fönster >>Broad-Spectrum Antidote Discovery by Untangling the Reactivation Mechanism of Nerve-Agent-Inhibited Acetylcholinesterase
Visa övriga...
2022 (Engelska)Ingår i: Chemistry - A European Journal, ISSN 0947-6539, E-ISSN 1521-3765, Vol. 28, nr 40, artikel-id e202200678Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Reactivators are vital for the treatment of organophosphorus nerve agent (OPNA) intoxication but new alternatives are needed due to their limited clinical applicability. The toxicity of OPNAs stems from covalent inhibition of the essential enzyme acetylcholinesterase (AChE), which reactivators relieve via a chemical reaction with the inactivated enzyme. Here, we present new strategies and tools for developing reactivators. We discover suitable inhibitor scaffolds by using an activity-independent competition assay to study non-covalent interactions with OPNA-AChEs and transform these inhibitors into broad-spectrum reactivators. Moreover, we identify determinants of reactivation efficiency by analysing reactivation and pre-reactivation kinetics together with structural data. Our results show that new OPNA reactivators can be discovered rationally by exploiting detailed knowledge of the reactivation mechanism of OPNA-inhibited AChE.

Ort, förlag, år, upplaga, sidor
John Wiley & Sons, 2022
Nyckelord
drug design, kinetics, nerve agent antidotes, reaction mechanisms, structural biology
Nationell ämneskategori
Farmakologi och toxikologi
Identifikatorer
urn:nbn:se:umu:diva-196525 (URN)10.1002/chem.202200678 (DOI)000807066300001 ()35420233 (PubMedID)2-s2.0-85131325691 (Scopus ID)
Forskningsfinansiär
Vetenskapsrådet, 2018-07152Forskningsrådet Formas, 2019-02496Vetenskapsrådet, 2018-05176
Tillgänglig från: 2022-06-14 Skapad: 2022-06-14 Senast uppdaterad: 2025-05-19Bibliografiskt granskad
Lindgren, C., Tyagi, M., Viljanen, J., Toms, J., Ge, C., Zhang, N., . . . Linusson, A. (2018). Dynamics Determine Signaling in a Multicomponent System Associated with Rheumatoid Arthritis. Journal of Medicinal Chemistry, 61(11), 4774-4790
Öppna denna publikation i ny flik eller fönster >>Dynamics Determine Signaling in a Multicomponent System Associated with Rheumatoid Arthritis
Visa övriga...
2018 (Engelska)Ingår i: Journal of Medicinal Chemistry, ISSN 0022-2623, E-ISSN 1520-4804, Vol. 61, nr 11, s. 4774-4790Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Strategies that target multiple components are usually required for treatment of diseases originating from complex biological systems. The multicomponent system consisting of the DR4 major histocompatibility complex type II molecule, the glycopeptide CI1259-273 from type II collagen, and a T-cell receptor is associated with development of rheumatoid arthritis (RA). We introduced non-native amino acids and amide bond isosteres into CI1259-273 and investigated the effect on binding to DR4 and the subsequent T-cell response. Molecular dynamics simulations revealed that complexes between DR4 and derivatives of CI1259-273 were highly dynamic. Signaling in the overall multicomponent system was found to depend on formation of an appropriate number of dynamic intramolecular hydrogen bonds between DR4 and CI1259-273, together with the positioning of the galactose moiety of CI1259-273 in the DR4 binding groove. Interestingly, the system tolerated modifications at several positions in CI1259-273, indicating opportunities to use analogues to increase our understanding of how rheumatoid arthritis develops and for evaluation as vaccines to treat RA.

Ort, förlag, år, upplaga, sidor
American Chemical Society (ACS), 2018
Nationell ämneskategori
Läkemedelskemi
Identifikatorer
urn:nbn:se:umu:diva-150782 (URN)10.1021/acs.jmedchem.7b01880 (DOI)000435613100008 ()29727183 (PubMedID)2-s2.0-85046659349 (Scopus ID)
Tillgänglig från: 2018-08-31 Skapad: 2018-08-31 Senast uppdaterad: 2023-03-24Bibliografiskt granskad
Knutsson, S., Engdahl, C., Kumari, R., Forsgren, N., Lindgren, C., Kindahl, T., . . . Linusson, A. (2018). Noncovalent Inhibitors of Mosquito Acetylcholinesterase 1 with Resistance-Breaking Potency. Journal of Medicinal Chemistry, 61(23), 10545-10557
Öppna denna publikation i ny flik eller fönster >>Noncovalent Inhibitors of Mosquito Acetylcholinesterase 1 with Resistance-Breaking Potency
Visa övriga...
2018 (Engelska)Ingår i: Journal of Medicinal Chemistry, ISSN 0022-2623, E-ISSN 1520-4804, Vol. 61, nr 23, s. 10545-10557Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Resistance development in insects significantly threatens the important benefits obtained by insecticide usage in vector control of disease-transmitting insects. Discovery of new chemical entities with insecticidal activity is highly desired in order to develop new insecticide candidates. Here, we present the design, synthesis, and biological evaluation of phenoxyacetamide-based inhibitors of the essential enzyme acetylcholinesterase 1 (AChE1). AChE1 is a validated insecticide target to control mosquito vectors of, e.g., malaria, dengue, and Zika virus infections. The inhibitors combine a mosquito versus human AChE selectivity with a high potency also for the resistance-conferring mutation G122S; two properties that have proven challenging to combine in a single compound. Structure activity relationship analyses and molecular dynamics simulations of inhibitor protein complexes have provided insights that elucidate the molecular basis for these properties. We also show that the inhibitors demonstrate in vivo insecticidal activity on disease-transmitting mosquitoes. Our findings support the concept of noncovalent, selective, and resistance-breaking inhibitors of AChE1 as a promising approach for future insecticide development.

Ort, förlag, år, upplaga, sidor
American Chemical Society (ACS), 2018
Nationell ämneskategori
Läkemedelskemi
Identifikatorer
urn:nbn:se:umu:diva-154812 (URN)10.1021/acs.jmedchem.8b01060 (DOI)000453488200014 ()30339371 (PubMedID)2-s2.0-85058504373 (Scopus ID)
Forskningsfinansiär
Vetenskapsrådet, 2014-4218Vetenskapsrådet, 2014-2636
Tillgänglig från: 2019-01-07 Skapad: 2019-01-07 Senast uppdaterad: 2023-03-23Bibliografiskt granskad
Organisationer

Sök vidare i DiVA

Visa alla publikationer